drugset / Trial / NCT05360147
Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
RandomizedParallel-groupSingle-blindTreatment
Summary
Patients with diabetes are susceptible to dementia, but regular therapy fails to reduce the risk of dementia. In previous observational study, the investigators found that liraglutide can improve cognitive function in patients with T2DM through a metabolism-independent pathway. Here the investigators aim to further verify such effects through a randomized, controlled study.
Timeline
- Start
- 2021-01-20
- Primary completion
- 2021-04-20
- Completion
- 2021-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | 1.8 mg | — |
| Comparator | Metformin | Small molecule | — | — |